10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

EYE (Nova EYE Medical Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze Nova EYE Medical Ltd together

I guess you are interested in Nova EYE Medical Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Nova EYE Medical Ltd’s Financial Insights
  • 📈 Technical Analysis (TA) – Nova EYE Medical Ltd’s Price Targets

I'm going to help you getting a better view of Nova EYE Medical Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Nova EYE Medical Ltd

I send you an email if I find something interesting about Nova EYE Medical Ltd.

1. Quick Overview

1.1. Quick analysis of Nova EYE Medical Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Nova EYE Medical Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
A$0.08
Expected worth in 1 year
A$0.05
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
A$-0.03
Return On Investment
-21.8%

For what price can you sell your share?

Current Price per Share
A$0.12
Expected price per share
A$0.1 - A$0.115
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Nova EYE Medical Ltd (5 min.)




Live pricePrice per Share (EOD)
A$0.12
Intrinsic Value Per Share
A$-0.36 - A$0.22
Total Value Per Share
A$-0.28 - A$0.30

2.2. Growth of Nova EYE Medical Ltd (5 min.)




Is Nova EYE Medical Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$14m$15.2m-$1.2m-8.7%

How much money is Nova EYE Medical Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$5.7m-$10m$4.2m74.0%
Net Profit Margin-37.7%-89.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Nova EYE Medical Ltd (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#206 / 298

Most Revenue
#155 / 298

Most Profit
#219 / 298

Most Efficient
#195 / 298
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Nova EYE Medical Ltd?

Welcome investor! Nova EYE Medical Ltd's management wants to use your money to grow the business. In return you get a share of Nova EYE Medical Ltd.

First you should know what it really means to hold a share of Nova EYE Medical Ltd. And how you can make/lose money.

Speculation

The Price per Share of Nova EYE Medical Ltd is A$0.12. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nova EYE Medical Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nova EYE Medical Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.08. Based on the TTM, the Book Value Change Per Share is A$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nova EYE Medical Ltd.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.02-16.9%-0.02-16.9%-0.04-29.5%-0.02-20.3%0.00-0.1%0.00-1.4%
Usd Book Value Change Per Share0.00-3.6%0.00-3.6%-0.02-13.9%-0.01-9.0%-0.02-18.3%0.00-3.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.0215.0%0.0214.9%
Usd Total Gains Per Share0.00-3.6%0.00-3.6%-0.02-13.9%-0.01-9.0%0.00-3.4%0.0111.9%
Usd Price Per Share0.14-0.14-0.17-0.15-0.22-0.34-
Price to Earnings Ratio-7.11--7.11--4.92--6.35--6.90--28.78-
Price-to-Total Gains Ratio-33.59--33.59--10.45--18.23--10.58-6.20-
Price to Book Ratio2.93-2.93-3.25-2.64-2.48-3.03-
Price-to-Total Gains Ratio-33.59--33.59--10.45--18.23--10.58-6.20-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.078888
Number of shares12676
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share0.00-0.02
Usd Total Gains Per Share0.000.00
Gains per Quarter (12676 shares)-54.58-50.99
Gains per Year (12676 shares)-218.31-203.98
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-218-228910-1114-214
20-437-4461819-2227-418
30-655-6642729-3341-622
40-873-8823639-4455-826
50-1092-11004548-5568-1030
60-1310-13185458-6682-1234
70-1528-15366368-7795-1438
80-1746-17547277-8909-1642
90-1965-19728187-10023-1846
100-2183-21909097-11136-2050

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.07.00.030.0%11.018.07.030.6%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%5.05.00.050.0%17.019.00.047.2%
Dividend per Share0.00.01.00.0%0.00.03.00.0%2.00.03.040.0%4.00.06.040.0%6.00.030.016.7%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%6.04.00.060.0%19.017.00.052.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Nova EYE Medical Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.007-0.0070%-0.025+287%-0.016+151%-0.033+410%-0.005-16%
Book Value Per Share--0.0750.0750%0.082-8%0.088-15%0.148-49%0.175-57%
Current Ratio--2.5952.5950%2.327+12%2.986-13%4.348-40%3.259-20%
Debt To Asset Ratio--0.2860.2860%0.236+21%0.231+24%0.198+45%0.259+11%
Debt To Equity Ratio--0.4010.4010%0.309+30%0.305+31%0.253+59%0.362+11%
Dividend Per Share----0%-0%-0%0.027-100%0.027-100%
Enterprise Value--60111116.48060111116.4800%75551685.760-20%63333936.427-5%112956558.656-47%148216527.744-59%
Eps---0.031-0.0310%-0.054+74%-0.037+20%0.000-99%-0.003-92%
Ev To Ebitda Ratio---10.054-10.0540%-7.968-21%-8.303-17%-20.039+99%0.486-2167%
Ev To Sales Ratio--2.5772.5770%4.438-42%3.692-30%8.011-68%5.919-56%
Free Cash Flow Per Share---0.029-0.0290%-0.026-9%-0.031+5%-0.027-9%-0.018-40%
Free Cash Flow To Equity Per Share---0.005-0.0050%-0.002-49%-0.015+205%-0.070+1324%-0.023+373%
Gross Profit Margin--1.3451.3450%1.209+11%1.264+6%1.211+11%1.295+4%
Intrinsic Value_10Y_max--0.222----------
Intrinsic Value_10Y_min---0.355----------
Intrinsic Value_1Y_max---0.009----------
Intrinsic Value_1Y_min---0.032----------
Intrinsic Value_3Y_max---0.003----------
Intrinsic Value_3Y_min---0.100----------
Intrinsic Value_5Y_max--0.031----------
Intrinsic Value_5Y_min---0.172----------
Market Cap34097518.080-83%62512116.48062512116.4800%75298685.760-17%63459269.760-1%94904758.656-34%146619327.744-57%
Net Profit Margin---0.377-0.3770%-0.898+138%-0.612+62%-0.542+44%-0.313-17%
Operating Margin---0.384-0.3840%-0.692+80%-0.600+56%-0.550+43%-0.317-18%
Operating Ratio--1.3841.3840%1.696-18%1.606-14%1.550-11%1.323+5%
Pb Ratio1.599-83%2.9312.9310%3.247-10%2.636+11%2.480+18%3.025-3%
Pe Ratio-3.879+45%-7.112-7.1120%-4.924-31%-6.349-11%-6.901-3%-28.778+305%
Price Per Share0.120-83%0.2200.2200%0.265-17%0.223-1%0.334-34%0.516-57%
Price To Free Cash Flow Ratio-4.105+45%-7.526-7.5260%-10.012+33%-7.551+0%4.482-268%272.554-103%
Price To Total Gains Ratio-18.322+45%-33.591-33.5910%-10.449-69%-18.228-46%-10.578-69%6.198-642%
Quick Ratio--1.8001.8000%1.490+21%1.964-8%3.405-47%2.290-21%
Return On Assets---0.294-0.2940%-0.504+71%-0.334+14%-0.233-21%-0.122-58%
Return On Equity---0.412-0.4120%-0.659+60%-0.439+7%-0.302-27%-0.159-61%
Total Gains Per Share---0.007-0.0070%-0.025+287%-0.016+151%-0.006-7%0.022-130%
Usd Book Value--14022342.00014022342.0000%15245763.400-8%16417031.067-15%27721111.720-49%32729513.620-57%
Usd Book Value Change Per Share---0.004-0.0040%-0.017+287%-0.011+151%-0.022+410%-0.004-16%
Usd Book Value Per Share--0.0490.0490%0.054-8%0.058-15%0.098-49%0.115-57%
Usd Dividend Per Share----0%-0%-0%0.018-100%0.018-100%
Usd Enterprise Value--39517047.97439517047.9740%49667678.219-20%41635729.807-5%74257641.660-47%97437545.339-59%
Usd Eps---0.020-0.0200%-0.035+74%-0.024+20%0.000-99%-0.002-92%
Usd Free Cash Flow---5460364.400-5460364.4000%-4944305.400-9%-5719599.133+5%-4954560.840-9%-3273326.080-40%
Usd Free Cash Flow Per Share---0.019-0.0190%-0.017-9%-0.020+5%-0.017-9%-0.012-40%
Usd Free Cash Flow To Equity Per Share---0.003-0.0030%-0.002-49%-0.010+205%-0.046+1324%-0.015+373%
Usd Market Cap22415708.386-83%41095465.37441095465.3740%49501356.019-17%41718123.940-1%62390388.340-34%96387546.059-57%
Usd Price Per Share0.079-83%0.1450.1450%0.174-17%0.147-1%0.220-34%0.339-57%
Usd Profit---5778546.000-5778546.0000%-10053618.200+74%-6920011.533+20%-5643910.480-2%-3342747.520-42%
Usd Revenue--15333855.00015333855.0000%11192235.000+37%11773595.733+30%10504068.680+46%25181444.040-39%
Usd Total Gains Per Share---0.004-0.0040%-0.017+287%-0.011+151%-0.004-7%0.014-130%
 EOD+3 -5MRQTTM+0 -0YOY+19 -193Y+21 -175Y+13 -2710Y+6 -34

3.3 Fundamental Score

Let's check the fundamental score of Nova EYE Medical Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.879
Price to Book Ratio (EOD)Between0-11.599
Net Profit Margin (MRQ)Greater than0-0.377
Operating Margin (MRQ)Greater than0-0.384
Quick Ratio (MRQ)Greater than11.800
Current Ratio (MRQ)Greater than12.595
Debt to Asset Ratio (MRQ)Less than10.286
Debt to Equity Ratio (MRQ)Less than10.401
Return on Equity (MRQ)Greater than0.15-0.412
Return on Assets (MRQ)Greater than0.05-0.294
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Nova EYE Medical Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.224
Ma 20Greater thanMa 500.115
Ma 50Greater thanMa 1000.117
Ma 100Greater thanMa 2000.113
OpenGreater thanClose0.115
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Nova EYE Medical Ltd

Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in adult patients with open-angle glaucoma; iTrack Advance, a canaloplasty microcatheter which offers malleability and manoeuvrability than common nylon alternatives; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.

Fundamental data was last updated by Penke on 2025-06-19 05:25:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Nova EYE Medical Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Nova EYE Medical Ltd to the Medical Devices industry mean.
  • A Net Profit Margin of -37.7% means that $-0.38 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nova EYE Medical Ltd:

  • The MRQ is -37.7%. The company is making a huge loss. -2
  • The TTM is -37.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-37.7%TTM-37.7%0.0%
TTM-37.7%YOY-89.8%+52.1%
TTM-37.7%5Y-54.2%+16.5%
5Y-54.2%10Y-31.3%-22.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-37.7%-7.7%-30.0%
TTM-37.7%-10.2%-27.5%
YOY-89.8%-10.9%-78.9%
3Y-61.2%-12.8%-48.4%
5Y-54.2%-10.3%-43.9%
10Y-31.3%-9.3%-22.0%
4.3.1.2. Return on Assets

Shows how efficient Nova EYE Medical Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nova EYE Medical Ltd to the Medical Devices industry mean.
  • -29.4% Return on Assets means that Nova EYE Medical Ltd generated $-0.29 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nova EYE Medical Ltd:

  • The MRQ is -29.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -29.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-29.4%TTM-29.4%0.0%
TTM-29.4%YOY-50.4%+21.0%
TTM-29.4%5Y-23.3%-6.1%
5Y-23.3%10Y-12.2%-11.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.4%-2.1%-27.3%
TTM-29.4%-2.4%-27.0%
YOY-50.4%-3.1%-47.3%
3Y-33.4%-2.6%-30.8%
5Y-23.3%-2.6%-20.7%
10Y-12.2%-2.4%-9.8%
4.3.1.3. Return on Equity

Shows how efficient Nova EYE Medical Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nova EYE Medical Ltd to the Medical Devices industry mean.
  • -41.2% Return on Equity means Nova EYE Medical Ltd generated $-0.41 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nova EYE Medical Ltd:

  • The MRQ is -41.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -41.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-41.2%TTM-41.2%0.0%
TTM-41.2%YOY-65.9%+24.7%
TTM-41.2%5Y-30.2%-11.0%
5Y-30.2%10Y-15.9%-14.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-41.2%-1.9%-39.3%
TTM-41.2%-2.6%-38.6%
YOY-65.9%-2.6%-63.3%
3Y-43.9%-3.7%-40.2%
5Y-30.2%-4.2%-26.0%
10Y-15.9%-5.8%-10.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Nova EYE Medical Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Nova EYE Medical Ltd is operating .

  • Measures how much profit Nova EYE Medical Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nova EYE Medical Ltd to the Medical Devices industry mean.
  • An Operating Margin of -38.4% means the company generated $-0.38  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nova EYE Medical Ltd:

  • The MRQ is -38.4%. The company is operating very inefficient. -2
  • The TTM is -38.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-38.4%TTM-38.4%0.0%
TTM-38.4%YOY-69.2%+30.7%
TTM-38.4%5Y-55.0%+16.6%
5Y-55.0%10Y-31.7%-23.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-38.4%-12.1%-26.3%
TTM-38.4%-13.6%-24.8%
YOY-69.2%-9.9%-59.3%
3Y-60.0%-9.6%-50.4%
5Y-55.0%-9.5%-45.5%
10Y-31.7%-9.4%-22.3%
4.3.2.2. Operating Ratio

Measures how efficient Nova EYE Medical Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.38 means that the operating costs are $1.38 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Nova EYE Medical Ltd:

  • The MRQ is 1.384. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.384. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.384TTM1.3840.000
TTM1.384YOY1.696-0.311
TTM1.3845Y1.550-0.166
5Y1.55010Y1.323+0.228
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3841.395-0.011
TTM1.3841.367+0.017
YOY1.6961.275+0.421
3Y1.6061.337+0.269
5Y1.5501.349+0.201
10Y1.3231.321+0.002
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Nova EYE Medical Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Nova EYE Medical Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.60 means the company has $2.60 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Nova EYE Medical Ltd:

  • The MRQ is 2.595. The company is able to pay all its short-term debts. +1
  • The TTM is 2.595. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.595TTM2.5950.000
TTM2.595YOY2.327+0.268
TTM2.5955Y4.348-1.753
5Y4.34810Y3.259+1.089
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5952.516+0.079
TTM2.5952.611-0.016
YOY2.3272.651-0.324
3Y2.9862.949+0.037
5Y4.3483.539+0.809
10Y3.2593.302-0.043
4.4.3.2. Quick Ratio

Measures if Nova EYE Medical Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nova EYE Medical Ltd to the Medical Devices industry mean.
  • A Quick Ratio of 1.80 means the company can pay off $1.80 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nova EYE Medical Ltd:

  • The MRQ is 1.800. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.800. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.800TTM1.8000.000
TTM1.800YOY1.490+0.310
TTM1.8005Y3.405-1.604
5Y3.40510Y2.290+1.115
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8001.107+0.693
TTM1.8001.412+0.388
YOY1.4901.652-0.162
3Y1.9641.816+0.148
5Y3.4052.145+1.260
10Y2.2902.350-0.060
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Nova EYE Medical Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Nova EYE Medical Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nova EYE Medical Ltd to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.29 means that Nova EYE Medical Ltd assets are financed with 28.6% credit (debt) and the remaining percentage (100% - 28.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Nova EYE Medical Ltd:

  • The MRQ is 0.286. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.286. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.286TTM0.2860.000
TTM0.286YOY0.236+0.050
TTM0.2865Y0.198+0.088
5Y0.19810Y0.259-0.061
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2860.400-0.114
TTM0.2860.410-0.124
YOY0.2360.391-0.155
3Y0.2310.388-0.157
5Y0.1980.414-0.216
10Y0.2590.455-0.196
4.5.4.2. Debt to Equity Ratio

Measures if Nova EYE Medical Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nova EYE Medical Ltd to the Medical Devices industry mean.
  • A Debt to Equity ratio of 40.1% means that company has $0.40 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nova EYE Medical Ltd:

  • The MRQ is 0.401. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.401. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.401TTM0.4010.000
TTM0.401YOY0.309+0.092
TTM0.4015Y0.253+0.148
5Y0.25310Y0.362-0.109
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4010.554-0.153
TTM0.4010.636-0.235
YOY0.3090.589-0.280
3Y0.3050.631-0.326
5Y0.2530.647-0.394
10Y0.3620.754-0.392
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Nova EYE Medical Ltd generates.

  • Above 15 is considered overpriced but always compare Nova EYE Medical Ltd to the Medical Devices industry mean.
  • A PE ratio of -7.11 means the investor is paying $-7.11 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nova EYE Medical Ltd:

  • The EOD is -3.879. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.112. Based on the earnings, the company is expensive. -2
  • The TTM is -7.112. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.879MRQ-7.112+3.233
MRQ-7.112TTM-7.1120.000
TTM-7.112YOY-4.924-2.188
TTM-7.1125Y-6.901-0.211
5Y-6.90110Y-28.778+21.878
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-3.879-1.153-2.726
MRQ-7.112-1.449-5.663
TTM-7.112-1.183-5.929
YOY-4.924-1.829-3.095
3Y-6.349-1.328-5.021
5Y-6.901-1.482-5.419
10Y-28.778-1.435-27.343
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Nova EYE Medical Ltd:

  • The EOD is -4.105. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.526. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.526. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.105MRQ-7.526+3.421
MRQ-7.526TTM-7.5260.000
TTM-7.526YOY-10.012+2.486
TTM-7.5265Y4.482-12.009
5Y4.48210Y272.554-268.072
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-4.105-2.438-1.667
MRQ-7.526-3.182-4.344
TTM-7.526-1.554-5.972
YOY-10.012-3.394-6.618
3Y-7.551-2.971-4.580
5Y4.482-2.902+7.384
10Y272.554-3.337+275.891
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Nova EYE Medical Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 2.93 means the investor is paying $2.93 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Nova EYE Medical Ltd:

  • The EOD is 1.599. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.931. Based on the equity, the company is underpriced. +1
  • The TTM is 2.931. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.599MRQ2.931-1.332
MRQ2.931TTM2.9310.000
TTM2.931YOY3.247-0.316
TTM2.9315Y2.480+0.450
5Y2.48010Y3.025-0.545
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.5991.943-0.344
MRQ2.9311.993+0.938
TTM2.9312.254+0.677
YOY3.2472.669+0.578
3Y2.6362.718-0.082
5Y2.4803.855-1.375
10Y3.0254.251-1.226
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Nova EYE Medical Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Long-term Assets Other  -6,253-696-6,949-3,169-10,118-698-10,81615,0144,198



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets29,882
Total Liabilities8,552
Total Stockholder Equity21,330
 As reported
Total Liabilities 8,552
Total Stockholder Equity+ 21,330
Total Assets = 29,882

Assets

Total Assets29,882
Total Current Assets14,749
Long-term Assets15,133
Total Current Assets
Cash And Cash Equivalents 6,151
Net Receivables 4,081
Inventory 4,283
Other Current Assets 234
Total Current Assets  (as reported)14,749
Total Current Assets  (calculated)14,749
+/-0
Long-term Assets
Property Plant Equipment 3,902
Intangible Assets 7,033
Long-term Assets Other 4,198
Long-term Assets  (as reported)15,133
Long-term Assets  (calculated)15,133
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,683
Long-term Liabilities2,869
Total Stockholder Equity21,330
Total Current Liabilities
Short-term Debt 480
Accounts payable 3,566
Other Current Liabilities 1,637
Total Current Liabilities  (as reported)5,683
Total Current Liabilities  (calculated)5,683
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt2,869
Long-term Liabilities  (as reported)2,869
Long-term Liabilities  (calculated)2,869
+/-0
Total Stockholder Equity
Common Stock52,710
Retained Earnings -30,687
Accumulated Other Comprehensive Income -693
Total Stockholder Equity (as reported)21,330
Total Stockholder Equity (calculated)21,330
+/-0
Other
Capital Stock52,710
Cash and Short Term Investments 6,151
Common Stock Shares Outstanding 204,141
Liabilities and Stockholders Equity 29,882
Net Debt -2,802
Net Invested Capital 21,330
Net Working Capital 9,066
Property Plant and Equipment Gross 10,387
Short Long Term Debt Total 3,349



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301996-06-301995-06-301994-06-301993-06-301992-06-301991-06-301990-06-301989-06-30
> Total Assets 
3,878
1,392
1,198
844
545
305
1,226
1,762
1,733
1,015
567
534
1,146
38,769
37,075
38,314
39,055
46,476
63,687
71,941
50,905
51,578
48,382
44,932
47,346
54,228
58,980
71,990
86,542
103,465
99,893
116,742
41,994
36,625
30,357
29,882
29,88230,35736,62541,994116,74299,893103,46586,54271,99058,98054,22847,34644,93248,38251,57850,90571,94163,68746,47639,05538,31437,07538,7691,1465345671,0151,7331,7621,2263055458441,1981,3923,878
   > Total Current Assets 
1,384
1,071
918
653
381
147
1,072
1,607
1,579
785
356
342
1,008
13,463
12,895
13,673
15,588
19,567
30,415
33,142
33,155
34,210
30,531
24,392
25,962
29,157
33,570
42,825
48,692
61,218
57,732
102,905
26,326
15,589
14,600
14,749
14,74914,60015,58926,326102,90557,73261,21848,69242,82533,57029,15725,96224,39230,53134,21033,15533,14230,41519,56715,58813,67312,89513,4631,0083423567851,5791,6071,0721473816539181,0711,384
       Cash And Cash Equivalents 
199
55
22
287
202
85
1,051
284
341
634
214
200
376
939
1,059
756
-210
-134
2,740
830
1,632
3,220
1,048
1,849
786
1,768
4,593
7,283
9,244
23,067
15,372
95,649
17,801
8,000
7,419
6,151
6,1517,4198,00017,80195,64915,37223,0679,2447,2834,5931,7687861,8491,0483,2201,6328302,740-134-2107561,0599393762002146343412841,051852022872255199
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
487
0
0
0
0
46
167
275
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000275167460000487000000000000
       Net Receivables 
571
790
634
130
77
37
2
1,203
1,106
1
6
1
24
5,446
3,626
3,297
4,333
6,871
11,763
13,152
14,596
13,017
11,383
9,362
10,242
11,805
12,153
15,425
15,121
14,663
15,503
3,828
1,909
2,046
1,930
4,081
4,0811,9302,0461,9093,82815,50314,66315,12115,42512,15311,80510,2429,36211,38313,01714,59613,15211,7636,8714,3333,2973,6265,446241611,1061,20323777130634790571
       Inventory 
614
164
217
202
102
25
19
135
136
136
136
137
120
6,959
8,013
9,398
10,759
12,088
14,729
17,745
15,883
17,099
16,711
12,200
13,587
14,172
15,682
18,641
23,416
22,458
26,084
2,934
2,901
3,540
3,806
4,283
4,2833,8063,5402,9012,93426,08422,45823,41618,64115,68214,17213,58712,20016,71117,09915,88317,74514,72912,08810,7599,3988,0136,9591201371361361361351925102202217164614
   > Long-term Assets 
2,494
321
280
191
164
158
154
155
154
230
211
192
138
25,306
24,180
24,641
23,467
26,909
33,272
38,799
17,750
17,368
17,851
20,540
3,287
6,911
8,004
11,864
17,331
18,461
17,761
13,837
15,668
21,036
15,757
15,133
15,13315,75721,03615,66813,83717,76118,46117,33111,8648,0046,9113,28720,54017,85117,36817,75038,79933,27226,90923,46724,64124,18025,3061381922112301541551541581641912803212,494
       Property Plant Equipment 
2,322
321
260
191
157
150
146
147
46
122
103
84
70
3,564
3,684
4,621
4,480
7,110
2,732
3,761
9,691
8,896
8,949
8,953
2,473
3,078
3,635
7,771
13,452
14,576
13,730
2,912
3,506
2,945
2,362
3,902
3,9022,3622,9453,5062,91213,73014,57613,4527,7713,6353,0782,4738,9538,9498,8969,6913,7612,7327,1104,4804,6213,6843,5647084103122461471461501571912603212,322
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
21,054
19,949
18,844
17,737
18,844
21,465
21,680
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000021,68021,46518,84417,73718,84419,94921,0540000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
21,069
19,956
21
21
47
5,936
6,952
609
704
739
791
814
3,833
4,369
4,093
3,879
3,885
4,031
10,877
12,098
18,023
13,324
7,033
7,03313,32418,02312,09810,8774,0313,8853,8794,0934,3693,8338147917397046096,9525,93647212119,95621,0690000000000000
       Long-term Assets Other 
172
0
20
0
7
8
8
8
100
100
100
100
60
0
0
0
0
0
153
168
242
295
302
2,670
-3,287
-6,911
-8,004
-5,114
-6,543
-8,597
-8,942
-6,253
-6,949
-10,118
-10,816
4,198
4,198-10,816-10,118-6,949-6,253-8,942-8,597-6,543-5,114-8,004-6,911-3,2872,670302295242168153000006010010010010088870200172
> Total Liabilities 
209
464
102
103
59
25
22
47
91
44
48
201
356
7,963
6,485
7,836
10,065
11,332
20,307
24,000
20,854
18,391
18,060
12,874
16,517
17,278
19,186
23,733
29,609
30,221
31,097
16,156
6,659
6,228
7,166
8,552
8,5527,1666,2286,65916,15631,09730,22129,60923,73319,18617,27816,51712,87418,06018,39120,85424,00020,30711,33210,0657,8366,4857,96335620148449147222559103102464209
   > Total Current Liabilities 
196
464
102
103
56
22
19
46
91
44
48
201
356
5,713
4,292
5,545
7,771
9,041
15,222
19,662
19,775
16,261
16,716
8,574
15,342
13,873
15,611
18,642
28,321
22,561
29,326
14,358
4,687
3,863
6,274
5,683
5,6836,2743,8634,68714,35829,32622,56128,32118,64215,61113,87315,3428,57416,71616,26119,77519,66215,2229,0417,7715,5454,2925,71335620148449146192256103102464196
       Short-term Debt 
4
127
0
0
0
0
0
0
0
0
0
0
487
632
73
92
3,199
2,271
5,131
9,175
10,486
7,814
7,400
3,752
6,369
5,137
6,010
5,779
15,536
9,097
15,039
1,909
1,938
544
639
480
4806395441,9381,90915,0399,09715,5365,7796,0105,1376,3693,7527,4007,81410,4869,1755,1312,2713,199927363248700000000001274
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,224
8,979
14,914
1,554
1,422
0
0
0
0001,4221,55414,9148,97915,2240000000000000000000000000000
       Accounts payable 
178
143
46
30
0
0
0
0
90
41
43
83
331
2,575
2,072
3,119
2,474
3,944
5,688
4,379
3,141
2,927
3,669
674
4,632
2,915
3,561
5,266
4,276
2,232
7,468
3,826
2,003
2,407
4,311
3,566
3,5664,3112,4072,0033,8267,4682,2324,2765,2663,5612,9154,6326743,6692,9273,1414,3795,6883,9442,4743,1192,0722,5753318343419000003046143178
       Other Current Liabilities 
14
194
56
73
56
22
19
46
1
3
5
118
25
1,526
1,720
2,330
2,098
2,461
4,025
5,669
5,763
4,917
5,173
3,744
4,341
5,432
5,513
6,934
7,465
11,097
3,300
472
746
912
1,324
1,637
1,6371,3249127464723,30011,0977,4656,9345,5135,4324,3413,7445,1734,9175,7635,6694,0252,4612,0982,3301,7201,5262511853146192256735619414
   > Long-term Liabilities 
13
0
0
0
3
3
3
1
0
0
0
0
0
2,250
2,193
2,291
2,294
2,291
5,085
4,338
1,079
2,130
1,344
4,300
960
584
396
2,041
1,288
5,723
1,771
1,798
1,972
2,365
892
2,869
2,8698922,3651,9721,7981,7715,7231,2882,0413965849604,3001,3442,1301,0794,3385,0852,2912,2942,2912,1932,25000000133300013
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
747
2,390
99
5,902
42
1,433
1,760
1,399
892
0
08921,3991,7601,433425,902992,39074700000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,701
1,189
1,758
1,729
365
212
966
0
0
009662123651,7291,7581,1892,701000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,579
13,446
14,885
15,308
7,536
8,655
10,850
4,870
0
04,87010,8508,6557,53615,30814,88513,44611,579000000000000000000000000000
> Total Stockholder Equity
3,669
928
1,096
741
486
280
1,204
1,715
1,641
971
519
333
790
30,806
30,590
30,478
28,990
35,144
43,259
47,731
29,840
33,036
30,161
32,058
30,829
36,950
39,794
48,257
56,933
73,244
68,796
100,586
35,335
30,397
23,191
21,330
21,33023,19130,39735,335100,58668,79673,24456,93348,25739,79436,95030,82932,05830,16133,03629,84047,73143,25935,14428,99030,47830,59030,8067903335199711,6411,7151,2042804867411,0969283,669
   Common Stock
19,349
19,099
19,579
19,579
19,579
978
1,956
2,566
2,761
2,761
4,055
4,237
5,156
32,280
27,985
27,985
27,985
27,985
33,544
33,635
35,176
35,188
35,188
35,188
35,188
41,229
41,229
46,041
55,949
78,311
78,311
78,311
36,678
37,440
45,175
52,710
52,71045,17537,44036,67878,31178,31178,31155,94946,04141,22941,22935,18835,18835,18835,18835,17633,63533,54427,98527,98527,98527,98532,2805,1564,2374,0552,7612,7612,5661,95697819,57919,57919,57919,09919,349
   Retained Earnings 
-15,940
-18,681
-19,004
-19,539
-19,987
-1,676
-1,730
-1,868
-2,137
-2,807
-3,536
-3,903
-4,366
-1,251
0
-206
1,908
7,405
11,672
16,417
-6,199
-2,379
-3,089
-2,120
-2,936
-2,148
-468
2,559
1,665
-5,388
-11,161
24,634
892
-6,604
-21,897
-30,687
-30,687-21,897-6,60489224,634-11,161-5,3881,6652,559-468-2,148-2,936-2,120-3,089-2,379-6,19916,41711,6727,4051,908-2060-1,251-4,366-3,903-3,536-2,807-2,137-1,868-1,730-1,676-19,987-19,539-19,004-18,681-15,940
   Capital Surplus 000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000
   Other Stockholders Equity 
260
510
521
701
1,177
1,203
1,205
1,223
0
0
224
-4,236
246
3,765
0
0
0
0
0
0
0
0
-454
0
-1,423
-2,131
-967
-343
-681
0
1,646
-102,945
-37,570
-30,836
0
0
00-30,836-37,570-102,9451,6460-681-343-967-2,131-1,4230-454000000003,765246-4,236224001,2231,2051,2031,177701521510260



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.




5.6. Income Statements

Currency in AUD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue23,325
Cost of Revenue-3,132
Gross Profit20,19320,193
 
Operating Income (+$)
Gross Profit20,193
Operating Expense-29,161
Operating Income-8,968-8,968
 
Operating Expense (+$)
Research Development567
Selling General Administrative11,780
Selling And Marketing Expenses3,036
Operating Expense29,16115,383
 
Net Interest Income (+$)
Interest Income124
Interest Expense-70
Other Finance Cost-0
Net Interest Income54
 
Pretax Income (+$)
Operating Income-8,968
Net Interest Income54
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,790-9,146
EBIT - interestExpense = -9,038
-13,961
-8,720
Interest Expense70
Earnings Before Interest and Taxes (EBIT)-8,968-8,720
Earnings Before Interest and Taxes (EBITDA)-5,979
 
After tax Income (+$)
Income Before Tax-8,790
Tax Provision-0
Net Income From Continuing Ops-8,790-8,790
Net Income-8,790
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses27,122
Total Other Income/Expenses Net178-54
 

Technical Analysis of Nova EYE Medical Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nova EYE Medical Ltd. The general trend of Nova EYE Medical Ltd is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nova EYE Medical Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Nova EYE Medical Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Nova EYE Medical Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.115 < 0.115 < 0.115.

The bearish price targets are: 0.1 > 0.1 > 0.1.

Know someone who trades $EYE? Share this with them.👇

Nova EYE Medical Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Nova EYE Medical Ltd. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Nova EYE Medical Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Nova EYE Medical Ltd. The current macd is -0.00111091.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nova EYE Medical Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Nova EYE Medical Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Nova EYE Medical Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Nova EYE Medical Ltd Daily Moving Average Convergence/Divergence (MACD) ChartNova EYE Medical Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Nova EYE Medical Ltd. The current adx is 15.43.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Nova EYE Medical Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Nova EYE Medical Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Nova EYE Medical Ltd. The current sar is 0.12037457.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Nova EYE Medical Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Nova EYE Medical Ltd. The current rsi is 54.22. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Nova EYE Medical Ltd Daily Relative Strength Index (RSI) ChartNova EYE Medical Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Nova EYE Medical Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nova EYE Medical Ltd price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Nova EYE Medical Ltd Daily Stochastic Oscillator ChartNova EYE Medical Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Nova EYE Medical Ltd. The current cci is 59.40.

Nova EYE Medical Ltd Daily Commodity Channel Index (CCI) ChartNova EYE Medical Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Nova EYE Medical Ltd. The current cmo is 15.94.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Nova EYE Medical Ltd Daily Chande Momentum Oscillator (CMO) ChartNova EYE Medical Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Nova EYE Medical Ltd. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Nova EYE Medical Ltd Daily Williams %R ChartNova EYE Medical Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Nova EYE Medical Ltd.

Nova EYE Medical Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Nova EYE Medical Ltd. The current atr is 0.00722162.

Nova EYE Medical Ltd Daily Average True Range (ATR) ChartNova EYE Medical Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Nova EYE Medical Ltd. The current obv is -20,310,729.

Nova EYE Medical Ltd Daily On-Balance Volume (OBV) ChartNova EYE Medical Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Nova EYE Medical Ltd. The current mfi is 21.18.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Nova EYE Medical Ltd Daily Money Flow Index (MFI) ChartNova EYE Medical Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Nova EYE Medical Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-17MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-05-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-24BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-03MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Nova EYE Medical Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Nova EYE Medical Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.224
Ma 20Greater thanMa 500.115
Ma 50Greater thanMa 1000.117
Ma 100Greater thanMa 2000.113
OpenGreater thanClose0.115
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Nova EYE Medical Ltd with someone you think should read this too:
  • Are you bullish or bearish on Nova EYE Medical Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nova EYE Medical Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Nova EYE Medical Ltd

I send you an email if I find something interesting about Nova EYE Medical Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Nova EYE Medical Ltd.

Receive notifications about Nova EYE Medical Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.